Targeted reduction of advanced glycation improves renal function in obesity
Brooke E. Harcourt(Albert Einstein College of Medicine), Josephine M. Forbes(Translational Research Institute), Maximilian de Courten(Victoria University), Bronwyn A. Kingwell(Baker Heart and Diabetes Institute), Karen Z. Walker(Baker Heart and Diabetes Institute), Sofianos Andrikopoulos(The University of Melbourne), Melinda T. Coughlan(Baker Heart and Diabetes Institute), Mark E. Cooper(Baker Heart and Diabetes Institute), Angelika Bierhaus(Heidelberg University), Vibhasha Chand(Baker Heart and Diabetes Institute), Vicki Thallas‐Bonke(Albert Einstein College of Medicine), Barbora de Courten(Monash Health), Sonia Dougherty(Baker Heart and Diabetes Institute), Karly C. Sourris(Baker Heart and Diabetes Institute), Merlin C. Thomas(Baker Heart and Diabetes Institute), Sally A. Penfold(Albert Einstein College of Medicine), Amy L. Morley(Baker Heart and Diabetes Institute)
Cited by 122
Related Papers
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Diabetic kidney disease
|Nature Reviews Disease Primers|2015|1.2k
Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes
|New England Journal of Medicine|2014|624
RAGE-Induced Cytosolic ROS Promote Mitochondrial Superoxide Generation in Diabetes
|Journal of the American Society of Nephrology|2009|461